Harvest Volatility Management LLC Incyte Corp Transaction History

Harvest Volatility Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $645,181 - $754,884	-10,186 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $266,439 - $325,997	3,880 Added 61.53%	10,186 $701,000
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $122,600 - $134,358	1,535 Added 32.17%	6,306 $531,000
Q1 2021 May 06, 2021	BUY	$76.02 - $100.5 $139,192 - $184,015	1,831 Added 62.28%	4,771 $388,000
Q4 2020 Mar 08, 2021	BUY	$80.74 - $97.7 $237,375 - $287,238	2,940 New	2,940 $256,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Harvest Volatility Management LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Volatility Management LLC with notifications on news.